FDA Adverse Event Injury Summary report: N

XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 3250452 · Received July 26, 2013

Report

Report Number
2024168-2013-04704
Event Type
Injury
Date Received
July 26, 2013
Date of Event
June 28, 2013
Report Date
July 1, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WERE NO REPORTED PRODUCT DEFICIENCIES. THE REPORTED PATIENT EFFECTS OF ANGINA AND THROMBOSIS ARE LISTED IN THE XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE AS KNOWN PATIENT EFFECTS OF CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE IF ANY CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MODERATELY TORTUOUS, HEAVILY CALCIFIED, CONCENTRIC MID AND PROXIMAL RIGHT CORONARY ARTERY. ON (B)(6) 2013 A 3.0 X 28 MM XIENCE PRIME WAS IMPLANTED IN THE PROXIMAL TO MID RIGHT CORONARY ARTERY. POST-DILATATION WAS PERFORMED AND USING INTRAVASCULAR ULTRASOUND (IVUS), THE STENT WAS CONFIRMED TO BE FULLY APPOSED. ON (B)(6) 2013 THE PATIENT EXPERIENCED CHEST PAIN. ANGIOGRAPHY WAS PERFORMED AND IN-STENT THROMBOSIS WAS CONFIRMED. A NON-ABBOTT STENT WAS IMPLANTED TO TREAT THE THROMBOSIS. THE PATIENT'S CONDITION WAS GOOD. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
349761 XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 2091841

Patients

Seq Age Sex Outcome Treatment
1 65 YR Hospitalization| R